The realm of weight management drugs witnessed a significant progress with the Food and Drug Association’s approval of Ozempic for chronic weight management. Widely known under the generic name Semaglutide, Ozempic was initially developed for controlling blood sugar in adults with type 2 diabetes.
Developed by Danish multinational pharmaceutical company Novo Nordisk, Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist. It complements the body’s insulin production, thereby assisting in managing blood sugar levels.
Ozempic gained FDA approval in December 2017, as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes. The groundbreaking medication has significantly broadened treatment options for patients struggling with this chronic condition.
Weight loss purposes
Studies and reports have consistently shown that one of the benefits of ozempic for weight loss is in its appetite suppressing properties. It helps patients feel full sooner, thus reducing caloric intake and aiding weight loss. Substantial data and research have backed the effectiveness of Ozempic in weight management, this prompted the FDA’s subsequent approval in 2020, recognizing Ozempic as an effective treatment for chronic weight management in adults with a body mass index of 30 or greater (obesity), or 27 or greater (overweight).
The approval for weight management was based on results from the STEP (Semaglutide Treatment Effect in People with obesity) program, which incorporated around 5,000 participants. In the trials, Ozempic significantly reduced weight and improved cardiovascular risk factors.
In conclusion, the FDA approval of Ozempic for both, type 2 diabetes and weight management, marks a noteworthy milestone in the healthcare sector. For more information on purchasing Ozempic, visit borderfreesupply.com. Its ability to effectively control blood sugar and aid weight loss, has carved a new path in chronic illness management, empowering patients to live healthier lives. It is, however, important to note that patients should always consult with their healthcare provider before starting any new medication regime.
